Swiss Electrical Stock News

Novartis (SWX:NOVN) agreed to acquire Excellergy, a biotech focused on anti IgE therapies for allergic diseases, including food allergies. The company reported positive final two year Phase III results for Fabhalta in IgA nephropathy, indicating slower kidney function decline in the study population. The FDA granted Fabhalta priority review for traditional approval in IgA nephropathy. For investors watching large pharma, Novartis sits at the intersection of immunology, allergy, and kidney...

The recent U.S. District Court order upholding a jury finding that Alcon (SWX:ALC) willfully infringed three Sight Sciences patents puts fresh attention on potential legal liabilities, ongoing Hydrus Microstent royalties, and appeal risk. See our latest analysis for Alcon. At a share price of CHF59.4, Alcon has a 1 day share price return of 0.58% and a 7 day share price return of 1.85%. However, a 1 year total shareholder return of 28.37% decline shows sentiment has cooled despite earlier...

PolyPeptide Group (SWX:PPGN) has expanded its credit facility to €200 million, bringing ING Bank into its lending group alongside UBS, Danske Bank and Zürcher Kantonalbank to support its revenue and capacity expansion objectives. See our latest analysis for PolyPeptide Group. That credit facility news arrives as momentum has been picking up, with the 7 day share price return of 8.54% and year to date share price return of 11.25% feeding into a 1 year total shareholder return of 62.61%. The...

Wondering whether Nestlé at around CHF 76.37 is priced for quality, or leaving some value on the table for patient shareholders? The stock is up 0.7% over the last week, while the 30 day return is a 9.1% decline and the one year return is a 12.3% decline, which may change how you think about both upside and risk. Recent coverage has focused on Nestlé's position as a global consumer staples giant, its broad portfolio of food and beverage brands, and how that scale influences investor...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Recent share performance snapshot Sandoz Group (SWX:SDZ) has seen a mix of short term pressure and longer term strength, with a 0.3% decline over the past day, 0.5% over the past week and 16.5% over the past month, but a 3.2% gain over the past 3 months and a 62.6% total return over the past year. See our latest analysis for Sandoz Group. The recent 30 day share price return of 16.5% contrasts with a 62.6% total shareholder return over the past year. This suggests that earlier gains have...

Nestlé is advancing the sale of its stake in its waters business, with private equity bidders moving forward in the process. The potential transaction is part of a broader effort to reshape the portfolio toward core areas such as coffee, pet food, nutrition, and food. The outcome of the bidding could influence how Nestlé allocates capital and manages its mix of brands in the coming years. For investors following SWX:NESN, this potential sale comes as the share price stands at CHF76.37, with...

As you might know, Newron Pharmaceuticals S.p.A. ( VTX:NWRN ) recently reported its annual numbers. It was a moderately...

Dividend and guidance draw attention to Medacta Group Medacta Group (SWX:MOVE) has attracted fresh investor interest after announcing an annual dividend of CHF 1.10 per share and issuing 2026 revenue growth guidance in a 10% to 14% range in constant currency. See our latest analysis for Medacta Group. The stock’s 1-day share price return of 1.62% contrasts with a weaker year-to-date share price return showing a 5.05% decline, while the 1-year total shareholder return of 14.85% points to...

In March 2026, Logitech International announced a new three-year share repurchase program of up to US$1.40 billion, alongside leadership changes and, on March 17, the global launch of the Logitech G RS H‑Shifter for sim racing enthusiasts. Together, the sizeable buyback authorization and expansion of Logitech’s high-end racing ecosystem highlight management’s focus on capital return and deepening engagement with committed gaming users. We’ll now examine how the US$1.40 billion share...

As European markets navigate heightened geopolitical tensions and soaring energy costs, investors are increasingly focused on the potential impact of these factors on inflation and economic stability. In this uncertain environment, dividend stocks may offer a measure of resilience by providing regular income streams that can help cushion against market volatility.

As European markets navigate the challenges of heightened energy prices and geopolitical tensions, investors are increasingly focused on companies that demonstrate resilience and potential for growth. In such uncertain times, stocks with high insider ownership can signal strong confidence from those who know the business best, making them attractive candidates for consideration in a volatile market environment.

Newron Pharmaceuticals (SWX:NWRN) has opened FY 2025 with first half revenue of €11.9 million and a basic EPS loss of €0.00, setting a cautious tone against a share price of CHF 14.64. Over recent periods, the company has seen revenue move from €3.4 million in H1 2024 to €48.0 million in H2 2024 and then to €11.9 million in H1 2025. Basic EPS has shifted from a loss of €0.51 in H1 2024 to a profit of €1.37 in H2 2024 and back to a marginal loss in the latest half, leaving investors focused on...

As European markets navigate heightened uncertainty stemming from geopolitical tensions and rising energy costs, investors are increasingly focusing on companies with strong fundamentals and insider confidence. In this environment, growth stocks with substantial insider ownership can offer a unique perspective on potential resilience and alignment of interests between management and shareholders.

Stadler Rail AG's ( VTX:SRAIL ) stock was strong after they recently reported robust earnings. We did some analysis and...

Investis Holding SA's ( VTX:IREN ) recent weak earnings report didn't cause a big stock movement. However, we believe...

Earnings event puts Medartis Holding (SWX:MED) in focus Medartis Holding (SWX:MED) is back on investors’ radar after reporting full year 2025 results, with higher sales, net income and earnings per share, followed by a special call on the same day. See our latest analysis for Medartis Holding. At a share price of CHF83.0, the stock has a 1 day share price return of 4.93% but a 30 day share price return that reflects a 12.17% decline. The 1 year total shareholder return of 9.35% suggests...

In recent weeks, SaltX Technology announced a Joint Development Agreement with Holcim to co-develop and pilot a fully electrified, fossil-free clinker production process in Europe, targeting the world’s first fully electric cement plant by 2028 and advancing electrified calcination and sintering technologies that can be retrofitted or built into new facilities. By pairing this deep-process electrification push with Holcim’s broader moves in low‑carbon manufacturing and equipment procurement,...

Galderma Group stock: recent performance snapshot Galderma Group (SWX:GALD) has drawn fresh attention after a period of mixed share performance, including a 0.3% move over the past day and a negative return over the past month and past 3 months. See our latest analysis for Galderma Group. That recent 7 day and 90 day share price weakness, with a 7 day share price return of a 1.93% decline and a 90 day share price return of a 13.16% decline from CHF142.5, contrasts with a 1 year total...

Index removal puts Adecco in focus for income minded investors Adecco Group (SWX:ADEN) has been removed from the FTSE All-World Index (USD), a shift that can prompt portfolio adjustments by index trackers, while its confirmed CHF 1.00 per share annual dividend keeps income considerations in view. See our latest analysis for Adecco Group. At a share price of CHF18.21, Adecco’s 30 day share price return of 15.46% and year to date share price return of 22.38%, alongside a 1 year total...

Galderma Group (SWX:GALD) has scheduled a virtual Annual General Meeting that will focus on corporate governance changes. The AGM agenda includes new board nominations linked to major shareholder L’Oréal and a proposed dividend. Management plans to discuss L’Oréal’s influence as an investor following a period of record company performance. Galderma Group operates in the dermatology and skincare segment, an area that continues to attract consumer interest as spending on skin health and...

Swiss Re (SWX:SREN) has attracted fresh attention after striking a US$2b longevity reinsurance deal with Athene, its first covering US retirees and a step that broadens its role in global pension risk transfer. See our latest analysis for Swiss Re. The longevity deal and recent leadership change in the Asia Pacific life and health unit come as Swiss Re’s share price sits at CHF128.0, with a small year to date share price decline and a much stronger multi year total shareholder return profile...

Recent share performance and business overview SMG Swiss Marketplace Group Holding (SWX:SMG) has drawn interest after a period of weaker share performance, with the stock closing at CHF 26.35 and showing negative returns over the past week, month and past 3 months. The company runs online marketplaces across real estate, automotive and general classifieds in Switzerland. It earned CHF 358.843m in revenue and CHF 67.694m in net income, supported by reported annual revenue and net income growth...

Givaudan, ticker SWX:GIVN, is participating in the Future Food-Tech San Francisco event. The company is highlighting its front end innovation capabilities, with its Head of Front End Innovation presenting. The event participation puts a spotlight on Givaudan's role in emerging food technology trends and potential collaboration opportunities. Givaudan enters this conference with its share price at CHF2,701.0 and a value score of 4, reflecting how some investors may currently view the stock...